Seattle startup HDT Bio will develop a nasal spray designed to counteract a wide range of respiratory viruses with a nearly $1.8 million grant from the U.S. Army. “We hope… Read More
Curevo has raised $60 million to develop a new vaccine for shingles, an often-painful condition caused by reactivation of the chickenpox virus. The new funding will enable the Seattle-based startup… Read More
An experimental COVID-19 vaccine in development by Seattle-based HDT Bio will enter early-stage clinical trials in the U.S., the company announced yesterday after the U.S. Food and Drug Administration cleared… Read More
Former “Geek of the Week” Rahul Singh is now VP of engineering at New York real estate broker Compass, where he’ll report to chief technology officer Joseph Sirosh. Singh was… Read More